You are here

COVID-19

States are prying loose vaccine supplies that were held in reserve

RICHMOND, Va. — When tiny glass vials of coronavirus vaccine began rolling off production lines late last year, federal health officials set aside a big stash for nursing homes being ravaged by the virus. Health providers around the country figured as well that it was prudent to squirrel away vials to ensure that everyone who got a first dose of vaccine got a second one.

Two months later, it is clear both strategies went overboard.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Suggestions onhow to buy a real N95 mask

A year into the coronavirus pandemic, buying a heavy-duty medical mask online remains downright maddening.

The most coveted mask to keep safe against Covid-19 has been the N95, the gold standard for pandemic protection because of its tight fit and 95 percent efficiency in filtering airborne particles. Then there’s the KN95 from China, a mask for medical workers, which also offers high filtration and is somewhat looser fitting.

But these masks have been far from easy to buy on the internet. When the pandemic hit last year, they immediately became scarce as health care workers and governments rushed to obtain them. The demand was so intense that a gray market sprang up for them.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

France establishes citizens' panel to counter vaccine antipathy

All across Europe, coronavirus vaccines are in scarce supply. But in France, they are also surprisingly unwanted: Recent polls suggest just 57% of the country intends to get vaccinated, whereas in the United Kingdom, 89% wants to get a shot for COVID-19.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Sharp drop in US life expectancy following pandemic emergence

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

White House coronavirus adviser says vaccine companies plan to update shots to address variants

White House coronavirus adviser official discusses plans by  vaccine companies cope with COVID-19 variants

Andy Slavitt, White House senior adviser on the coronavirus response, said vaccine-producing companies plan to update their shots to address variants of the virus.

During a Washington Post live interview Thursday, he said the Pfizer and Moderna vaccines “work well for” the most prominent variant spreading throughout the United States, which is the one first identified in Britain.

He said that while the vaccines appear less effective against the variants first identified in Brazil and South Africa, they do produce some antibodies.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID "Long haulers" --more background on their problems

How many people get ‘long COVID’ – and who is most at risk?

A few months ago, a young athletic guy came into my clinic where I’m an infectious disease physician and COVID-19 immunology researcher. He felt tired all the time, and, importantly to him, was having difficulty mountain biking. Three months earlier, he had tested positive for COVID-19. He is the kind of person you might expect to have a few days of mild symptoms before recovering fully. But when he walked into my clinic, he was still experiencing symptoms of COVID-19 and he could not mountain bike at the level he was able to before.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The difficulties in enrolling teenagers for vaccine test trials.

 

 

Teenagers contract the novel coronavirus almost twice as often as younger children but vaccines authorized in the United States are mostly for adults — Moderna’s for 18 and older, Pfizer’s for 16 and up.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to COVID-19
howdy folks
Page loaded in 1.364 seconds.